| Revenue growth | 20% YoY growth driven by patient volume and ARPP increases. |
|---|---|
| Margins | Improving; Operating EBITDA margin expanded 170 bps to 22.2%. |
| Demand visibility | High; 13% growth in patient volumes and 62% growth in MVT. |
| Management confidence | Strong; emphasizing disciplined execution and successful merger completion on schedule. |
Growth
Revenue grew 20% YoY to INR 2,597 Cr; Operating EBITDA surged 30% YoY to INR 576 Cr.
Outlook
Planned expansion of 4,179 beds by FY30 to reach 15,077 total capacity; aiming for 10-15% synergy-driven EBITDA uplift.
Risks
Indicative proforma numbers subject to audit adjustments and merger-related exceptional integration costs of INR 114.4 Cr.
Last quarter's promises, checked
Delivered
- Merger completion target Q1 FY27 → Completed on schedule (= BEAT)
- Operationalize 159-bed Whitefield block April 2026 → Commissioned (= BEAT)
- Operationalize 75-bed Ramesh Ongole April 2026 → Commissioned (= BEAT)
Partly delivered
- Target 2,500 beds over coming years → 159 beds added this quarter (= PARTIAL)
Investor Presentation filed with NSE, NSE: ASTERDM. Summary written with AI assistance from the document.
Aster DM Quality Care Ltd: key numbers
- Share price
- ₹759.40
- Market cap
- ₹66,195 Cr
- Revenue (annual)
- ₹4,643 Cr
- Net profit (annual)
- ₹388.1 Cr
- P/E (TTM)
- 207.7×Sector 57.8×
- Promoter holding
- 53.72%+13.33% QoQ
- FII holding
- 10.32%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aster DM Quality Care Ltd
All →Aster DM Quality Care Annual General Meeting
Aster DM Quality Care issued an addendum to its 18th AGM notice, providing additional information regarding the proposed capital allocation framework for shareholders.
Aster DM Quality Care Credit Rating
ICRA upgraded KIMS Healthcare Management's long-term rating to AA (Stable) from AA-, removing it from Rating Watch. The upgrade reflects stronger parent support post-Aster-QCIL merger.
Aster DM Quality Care Share Pledge
Catalyst Trusteeship released a pledge and created a new hold on Aster DM Quality Care shares. The encumbrance secures term loan facilities from Barclays and JPMorgan.
Aster DM Quality Care Share Pledge
UMHL released a pledge and created a non-disposal undertaking over 2.49 Cr shares securing USD 210 million. The encumbrance backs UIPL's Barclays-JPMorgan loan facilities.
- Value
- ₹1,974 Cr
Aster DM Quality Care Capacity Expansion: ₹134.4 Cr Investment
Aster DM announced KIMSHEALTH New Block adding ~184 beds by May 2028 at a cost of ₹134.4 Crore. The expansion addresses space constraints in Trivandrum.
- Value
- ₹134.4 Cr
- Execution
- on or before May 2028
- hospital beds
- 184 beds
Aster DM Quality Care Annual Report
Aster DM Quality Care has submitted its Integrated Annual Report for FY 2025-26 and the notice for its 18th Annual General Meeting scheduled for September 28, 2026.